If obesity market continues to develop, in spite of an increasing number of drugs Orexigen has great potential to become a big player in that market. Analysts estimate the obesity market to sixfold till 2020! And don't forget the potential Orexigen has in the EU as there it is almost the only company with an approved anti-obesity drug.
Hopefully the Q4/14 figures are positive and pps rises...
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.